Schlumberger NV vs BIO-TECHNE Corp — how do they compare? Schlumberger NV trades at $46.77 (market cap $69.36B), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: Schlumberger NV is far larger — about 6.2× BIO-TECHNE Corp's market cap, and Schlumberger NV pays the higher dividend (2.54%). Which is the better fit depends on your goals.
| SLB | TECH | |
|---|---|---|
Market Cap | $69.36B | $11.16B |
Sector | Energy | Health |
52-Week High | $58.01 | $72.12 |
52-Week Low | $31.72 | $43.31 |
Enterprise Value | $77.58B | $11.24B |
Dividend Yield | 2.54% | 0.45% |
Trailing returns across standard periods
Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →